Major study launches to track safety of new diabetes 'Artificial Pancreas' system
Disease control
Recruiting now
This study aims to collect real-world safety data on the Twiist automated insulin delivery system, which is designed to help manage type 1 diabetes. It will follow 1,875 adults and children in the U.S. who are already using the Twiist system for 12 months. The main goal is to tra…
Sponsor: Deka Research and Development • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC